[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100614512":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":11,"centralContacts":24,"locations":30,"responsibleParty":46,"collaborators":48,"id":61,"slug":62,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":11,"eligibilityCriteria":67,"healthyVolunteers":68,"sex":69,"minAge":70,"maxAge":71,"enrollmentInfo":72,"targetDuration":11,"studyType":75,"phases":76,"briefSummary":78,"conditions":79,"keywords":11,"overallStatus":81,"whyStopped":11,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":91},{"fullName":5,"class":6},"Taipei Veterans General Hospital, Taiwan","OTHER_GOV",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"AI-assisted LDCT Interpretation","EXPERIMENTAL",null,[13],"Diagnostic Test: AI-assisted Low-Dose CT Interpretation",{"label":15,"type":16,"description":17,"interventionNames":11},"Standard Radiologist LDCT Interpretation","NO_INTERVENTION","Participants undergo low-dose computed tomography (LDCT) lung cancer screening. Images are interpreted solely by radiologists without AI assistance.",[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":11},"DIAGNOSTIC_TEST","AI-assisted Low-Dose CT Interpretation","Participants undergo low-dose computed tomography (LDCT) lung cancer screening. The images are first interpreted by AI-assisted software, which highlights suspicious nodules. Radiologists then review the AI outputs and generate the final report.",[9],[25],{"name":26,"role":27,"phone":28,"phoneExt":11,"email":29},"Hao-Min Cheng, M.D., Ph.D","CONTACT","+886-2-28712121 ext 85322","hmcheng@vghtpe.gov.tw",[31],{"facility":32,"status":11,"city":33,"state":34,"zip":35,"country":34,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"Taipei Veterans General Hospital","Taipei","Taiwan","112","TW",{"type":38,"coordinates":39},"Point",[40,41],121.52639,25.05306,{"lat":41,"lon":40},[44],{"name":45,"role":27,"phone":28,"phoneExt":11,"email":29},"Hao-Min Cheng, M.D., Ph.D.",{"type":47,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR",[49,52,55,57,59],{"name":50,"class":51},"Far Eastern Memorial Hospital","OTHER",{"name":53,"class":54},"Taipei Municipal Guandu Hospital","UNKNOWN",{"name":56,"class":51},"Da Chien General Hospital",{"name":58,"class":54},"Kinmen Hospital, Ministry of Health and Welfare",{"name":60,"class":6},"Ministry of Health and Welfare, Taiwan","100614512","evaluation-of-ai-assisted-ldct-screening-in-lung-cancer-100614512",false,"NCT07280559","Evaluation of AI-assisted LDCT Screening in Lung Cancer","Evaluation of AI Medical Software-assisted LDCT Interpretation in Lung Cancer Screening and Prognosis: a Randomized Controlled Trial","Inclusion Criteria:\n\n1. Family History of Lung Cancer: Males aged 45-74 or females aged 40-74 with first-degree relatives (parents, siblings, or children) diagnosed with lung cancer.\n2. Heavy Smoking History: Ages 50-74 with ≥20 pack-years smoking history, currently smoking or quit \\\u003C15 years ago.\n3. General Screening Participants: Adults aged 40 years or older attending routine health check-ups.\n\nExclusion Criteria:\n\n1. Pregnant women.\n2. Chest CT or other higher-radiation chest imaging within the past 12 months.\n3. Individuals holding a major illness certificate for lung cancer.\n4. Inability to undergo thoracic puncture or surgery.\n5. Inability to hold breath or otherwise complete the scanning procedure.\n6. Hemoptysis of unknown cause within the past month.\n7. Chest X-ray within the past month showing suspicious lung lesions.\n8. Unexplained weight loss \\>6 kg within the past year.\n9. History of lung cancer within the past three years.\n10. Presence of other severe diseases with an expected life expectancy \\\u003C5 years.",true,"ALL","40 Years","74 Years",{"count":73,"type":74},1120,"ESTIMATED","INTERVENTIONAL",[77],"NA","This multicenter pragmatic randomized controlled trial evaluates whether AI-assisted interpretation of low-dose CT (LDCT) improves lung cancer screening performance compared with standard reading. Eligible participants are randomized to AI-assisted or conventional interpretation. The study assesses diagnostic accuracy, efficiency, lung cancer incidence, mortality, recurrence, and smoking cessation outcomes. Results will inform the clinical utility and potential implementation of AI-assisted LDCT in routine screening practice.",[80],"Lung Cancer","NOT_YET_RECRUITING","2025-12-09",{"date":84,"type":85},"2025-12-12","ACTUAL",{"date":87,"type":74},"2025-12-11",{"date":89,"type":74},"2031-12-31",{"name":5,"class":6},1]